CN112956627A - Compound solid drink of chaga for women - Google Patents
Compound solid drink of chaga for women Download PDFInfo
- Publication number
- CN112956627A CN112956627A CN202110037547.9A CN202110037547A CN112956627A CN 112956627 A CN112956627 A CN 112956627A CN 202110037547 A CN202110037547 A CN 202110037547A CN 112956627 A CN112956627 A CN 112956627A
- Authority
- CN
- China
- Prior art keywords
- extract
- parts
- drying
- concentrating
- inonotus obliquus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007787 solid Substances 0.000 title claims abstract description 22
- 150000001875 compounds Chemical class 0.000 title claims description 4
- 239000000284 extract Substances 0.000 claims abstract description 58
- 241000414067 Inonotus obliquus Species 0.000 claims abstract description 41
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 26
- 235000013361 beverage Nutrition 0.000 claims abstract description 20
- 229920001202 Inulin Polymers 0.000 claims abstract description 15
- 229940069521 aloe extract Drugs 0.000 claims abstract description 15
- 229940055416 blueberry extract Drugs 0.000 claims abstract description 15
- 235000019216 blueberry extract Nutrition 0.000 claims abstract description 15
- 229940029339 inulin Drugs 0.000 claims abstract description 15
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 15
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 13
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 13
- 239000011718 vitamin C Substances 0.000 claims abstract description 13
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 11
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229940013618 stevioside Drugs 0.000 claims abstract description 11
- 235000019202 steviosides Nutrition 0.000 claims abstract description 11
- 239000002131 composite material Substances 0.000 claims abstract description 10
- JYDNKGUBLIKNAM-UHFFFAOYSA-N Oxyallobutulin Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(CO)CCC(C(=C)C)C5C4CCC3C21C JYDNKGUBLIKNAM-UHFFFAOYSA-N 0.000 claims abstract description 9
- FVWJYYTZTCVBKE-ROUWMTJPSA-N betulin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(CO)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C FVWJYYTZTCVBKE-ROUWMTJPSA-N 0.000 claims abstract description 9
- MVIRREHRVZLANQ-UHFFFAOYSA-N betulin Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C2CC=C4C5C(CCC5(CO)CCC34C)C(=C)C)C1(C)C MVIRREHRVZLANQ-UHFFFAOYSA-N 0.000 claims abstract description 9
- 244000061520 Angelica archangelica Species 0.000 claims abstract description 8
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 48
- 238000001035 drying Methods 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 16
- 238000000605 extraction Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 13
- 238000004140 cleaning Methods 0.000 claims description 12
- 238000001704 evaporation Methods 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 238000002791 soaking Methods 0.000 claims description 8
- 241001116389 Aloe Species 0.000 claims description 7
- 241000382455 Angelica sinensis Species 0.000 claims description 7
- 235000011399 aloe vera Nutrition 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 6
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 238000007873 sieving Methods 0.000 claims description 6
- 238000001291 vacuum drying Methods 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 5
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 5
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 5
- 235000021014 blueberries Nutrition 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 230000002378 acidificating effect Effects 0.000 claims description 3
- 239000009188 angelicae sinensis extract Substances 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 238000005360 mashing Methods 0.000 claims description 3
- 239000012074 organic phase Substances 0.000 claims description 3
- 238000005325 percolation Methods 0.000 claims description 3
- 239000012071 phase Substances 0.000 claims description 3
- 238000004537 pulping Methods 0.000 claims description 3
- 241000037831 Polygonatum sibiricum Species 0.000 claims description 2
- 230000008020 evaporation Effects 0.000 claims description 2
- 230000006641 stabilisation Effects 0.000 claims description 2
- 238000011105 stabilization Methods 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 238000005550 wet granulation Methods 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 33
- 210000004369 blood Anatomy 0.000 abstract description 33
- 230000000694 effects Effects 0.000 abstract description 19
- 230000032683 aging Effects 0.000 abstract description 8
- 208000002193 Pain Diseases 0.000 abstract description 7
- 230000005906 menstruation Effects 0.000 abstract description 6
- 230000001105 regulatory effect Effects 0.000 abstract description 6
- 230000003796 beauty Effects 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 4
- 238000009776 industrial production Methods 0.000 abstract description 2
- 239000000419 plant extract Substances 0.000 abstract description 2
- 240000008042 Zea mays Species 0.000 description 30
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 27
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 27
- 235000005822 corn Nutrition 0.000 description 27
- 239000000203 mixture Substances 0.000 description 17
- 239000000243 solution Substances 0.000 description 15
- 235000019441 ethanol Nutrition 0.000 description 13
- 239000001963 growth medium Substances 0.000 description 10
- 241000747105 Fuscoporia Species 0.000 description 9
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 6
- 230000002708 enhancing effect Effects 0.000 description 6
- 239000012452 mother liquor Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 240000007594 Oryza sativa Species 0.000 description 5
- 235000007164 Oryza sativa Nutrition 0.000 description 5
- 241000756042 Polygonatum Species 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 235000009566 rice Nutrition 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 238000013329 compounding Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 229960004889 salicylic acid Drugs 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- -1 VB1 Chemical class 0.000 description 3
- 235000007244 Zea mays Nutrition 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 2
- 235000009109 Betula pendula Nutrition 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical class O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 244000236458 Panicum colonum Species 0.000 description 2
- 235000015225 Panicum colonum Nutrition 0.000 description 2
- 241000222341 Polyporaceae Species 0.000 description 2
- 244000062793 Sorghum vulgare Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000036983 biotransformation Effects 0.000 description 2
- 229940089639 cornsilk Drugs 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 235000019713 millet Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- 239000001231 zea mays silk Substances 0.000 description 2
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- OCZVHBZNPVABKX-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine;ethanol Chemical compound CCO.[O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 OCZVHBZNPVABKX-UHFFFAOYSA-N 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 244000274847 Betula papyrifera Species 0.000 description 1
- 235000009113 Betula papyrifera Nutrition 0.000 description 1
- 241000219430 Betula pendula Species 0.000 description 1
- 235000010928 Betula populifolia Nutrition 0.000 description 1
- 235000002992 Betula pubescens Nutrition 0.000 description 1
- 241000219495 Betulaceae Species 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000037111 Retinal Hemorrhage Diseases 0.000 description 1
- 208000007014 Retinitis pigmentosa Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 241001106462 Ulmus Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000014104 aloe vera supplement Nutrition 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000001648 tannin Chemical class 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Chemical class 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
- A23L2/395—Dry compositions in a particular shape or form
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The betulin composite solid beverage suitable for women comprises the following components in parts by weight: 15-18 parts of inonotus obliquus extract, 16-20 parts of rhizoma polygonati extract, 28-32 parts of blueberry extract, 3-7 parts of aloe extract, 3-7 parts of angelica extract, 22-28 parts of inulin, 4-6 parts of vitamin C and 0.5-0.8 part of stevioside. The betulin composite solid beverage suitable for women is mainly prepared from natural plant extracts, has the effects of tonifying qi and blood, regulating menstruation, relieving pain, resisting aging and maintaining beauty for women, and is suitable for industrial production in the field of food.
Description
Technical Field
The invention relates to the field of functional foods, in particular to a betulin composite solid beverage suitable for women.
Background
Inonotus obliquus, the scientific name Inonotus obliquus, is a fungus parasitic on the subcutaneous surface of living standing trees such as white birch, silver birch, elm, and alder or on the dead trunk of felled trees. The obtained Fuscoporia obliqua polysaccharide, lanosterol and triterpenoid oxide, Fuscoporia obliqua alcohol and Fuscoporia obliqua rhzomorph, melanin and tannin compounds, lignin, etc. have wide medicinal value, and have effects of lowering blood sugar, resisting tumor, resisting virus, enhancing immunity, etc. The traditional Chinese medicine holds that the inonotus obliquus mainly strengthens the body resistance, and can tonify qi and nourish blood, nourish yin and promote the production of body fluid, invigorate the spleen and stomach, nourish the liver and kidney, and tranquilize the mind; at the same time, it can also eliminate pathogenic factors, and has the actions of clearing away heat and toxic material, soothing liver, relieving depression, promoting blood circulation and resolving hard mass.
Rhizoma Polygonati is sweet and neutral in taste, has effects of invigorating qi, nourishing yin, moistening lung, and invigorating kidney, and can be used for treating weakness of spleen and stomach, tiredness, debilitation, xerostomia, cough due to lung deficiency, essence and blood deficiency, and internal heat diabetes. The blueberry is rich in anthocyanin and fiber, and has the functions of improving eyesight, enhancing autoimmunity, enhancing memory, resisting oxidation, resisting aging and the like. Aloe has antibacterial, antiinflammatory, and skin caring effects, and radix Angelicae sinensis has effects in replenishing blood, promoting blood circulation, regulating menstruation, and relieving pain. The angelica has sweet taste and warm nature, enters liver, heart and spleen channels, and has the functions of enriching blood and activating blood, regulating menstruation and relieving pain, and relaxing bowel.
The modern life of fast rhythm and high pressure leads women to have the problems of menstrual disorder, deficiency of qi and blood, dark and dim face and the like, and how to regulate the female is an important problem.
Disclosure of Invention
In order to solve the existing problems, the invention provides the betulin composite solid beverage suitable for women, and the solid beverage has the functions of maintaining beauty and keeping young, resisting aging, tonifying qi and blood, regulating menstruation and relieving pain for women. The invention is realized by the following technical scheme.
The invention aims to provide a betulin composite solid beverage suitable for women, which comprises the following components in parts by weight:
15-18 parts of inonotus obliquus extract, 16-20 parts of rhizoma polygonati extract, 28-32 parts of blueberry extract, 3-7 parts of aloe extract, 3-7 parts of angelica extract, 22-28 parts of inulin, 4-6 parts of vitamin C and 0.5-0.8 part of stevioside.
Wherein the Fuscoporia obliqua extract is prepared from wild Fuscoporia obliqua or artificially cultured Fuscoporia obliqua mycelium.
Preferably, the inonotus obliquus composite solid beverage comprises the following components in parts by weight:
15 parts of inonotus obliquus extract, 18 parts of rhizoma polygonati extract, 27 parts of blueberry extract, 4.7 parts of aloe extract, 4.7 parts of angelica sinensis extract, 15.3 parts of inulin, 4.7 parts of vitamin C and 0.6 part of stevioside.
In addition, the invention also provides a preparation method of the betulin composite solid beverage suitable for women, which comprises the following steps:
(1) cleaning Chaba, drying, pulverizing, sieving, adding Chaba powder into an extraction kettle, adding 70% ethanol according to the weight ratio of 1:8-1:10 of the material liquid, extracting at 55-63 deg.C for 4-5 h, filtering, extracting the residue for the second time, concentrating the extractive solution, and drying to obtain Chaba extract.
(2) Removing impurities from rhizoma polygonati, cleaning, drying, crushing and sieving, putting rhizoma polygonati powder into an extraction kettle, adding distilled water according to the weight ratio of 1:3-1:5 of material liquid, soaking for 3-4h at 55-60 ℃, separating extract, performing secondary extraction, evaporating and concentrating, adding 3-5 times of 90% alcohol, standing for 3-4h, concentrating separated supernatant, washing lower substances with 90% alcohol, concentrating washing liquid again, mixing the two concentrates, and performing vacuum drying to obtain the rhizoma polygonati extract.
(3) Cleaning blueberries, pulping, putting pulp into an extraction kettle, and mixing the pulp according to a feed liquid weight ratio of 1:8-1:10 adding 70% acidic ethanol, soaking at 55-60 deg.C for 1-2h, centrifuging at 1200r/min for 20min, evaporating the supernatant, concentrating, and vacuum drying at 55 deg.C to obtain fructus Myrtilli extract.
(4) Cleaning Aloe, peeling, mashing to obtain slurry, vacuum evaporating at 40 deg.C for concentration, extracting with ethyl acetate at 55-60 deg.C for 3 times, discarding organic phase, combining three water phases, evaporating for concentration, dissolving the obtained concentrate with isobutanol at 70 deg.C, cooling to 4-5 deg.C, crystallizing, and drying the separated crystal to obtain Aloe extract.
(5) Drying and pulverizing radix Angelicae sinensis, adding 70% ethanol at a weight ratio of 1:1-1:1.5, soaking for 2-3 hr, placing in a percolation barrel, percolating at a speed of 1mL/min, collecting 18-20 times of percolate, recovering ethanol under reduced pressure, and drying the rest liquid to obtain radix Angelicae sinensis extract.
(6) And (2) uniformly mixing the inonotus obliquus extract obtained in the step (1), the polygonatum sibiricum extract obtained in the step (2), the blueberry extract obtained in the step (3), the aloe extract obtained in the step (4), the angelica sinensis extract obtained in the step (5), inulin, vitamin C and stevioside in proportion, performing wet granulation, drying, and performing size stabilization, sterilization and packaging to obtain the inonotus obliquus composite solid beverage.
The invention introduces the effects of each component:
the efficacy of the inonotus obliquus extract: the active ingredients in the Inonotus obliquus extract comprise Inonotus obliquus polysaccharide, water-soluble fiber, triterpenoid, SOD, multiple minerals, vitamins, etc., and have effects of resisting tumor, preventing and treating diabetes, preventing and treating hypertension, resisting aging, enhancing immunity, resisting inflammation, relieving pain, resisting virus, resisting platelet aggregation, protecting liver, and improving and preventing allergic skin.
The efficacy of the polygonatum extract is as follows: the active ingredients of the polygonatum extract comprise polygonatum polysaccharide, polygonatum oligosaccharide, nicotinic acid, quinone compounds and the like, have the effects of resisting pathogenic microorganisms such as staphylococcus aureus and herpes virus, reducing blood sugar and blood fat, improving atherosclerosis and enhancing cellular immune function, and are clinically used for treating pulmonary tuberculosis, ringworm, cold and heat deficiency of the old, poor appetite and weakness, weak bones and muscles, soreness and weakness of waist and knees, coronary heart disease, hyperlipidaemia, diabetes, chronic hepatitis, leukopenia, low immune function and the like.
The blueberry extract has the following effects: the blueberry extract mainly contains anthocyanin as an active ingredient, has the effects of protecting vision, preventing blindness, glaucoma, cataract and retinal hemorrhage, improving myopia, macular degeneration, diabetic retinopathy, retinitis pigmentosa, nyctalopia and the like, can increase the flexibility of capillary vessels, promote the expansion and flexibility of the blood vessels, prevent the blood vessels from being ruptured, has strong antioxidant capacity, can eliminate free radicals for hardening the blood vessels, and prevents arteriosclerosis.
Efficacy of aloe vera extract: aloe has antibacterial, antiinflammatory, toxic materials clearing away, wound healing promoting, stomach invigorating, laxative, anticancer, skin caring, and immunity enhancing effects. In beautifying skin, aloe has the functions of resisting allergy, softening skin, repeating acne, effectively inhibiting ultraviolet rays, preventing pigmentation, keeping skin white and fine, and delaying aging.
The efficacy of the angelica extract is as follows: the angelica has the effects of enriching blood and activating blood, regulating menstruation and relieving pain, and loosening the bowel to relieve constipation, and is mainly used for treating blood deficiency and chlorosis, dizziness and palpitation, irregular menstruation, amenorrhea and dysmenorrheal, deficiency-cold abdominal pain, rheumatic arthralgia, traumatic injury, carbuncle, cellulitis, sore injury, and constipation due to intestinal dryness in traditional Chinese medicine.
The efficacy of inulin is as follows: inulin can control blood sugar, reduce blood sugar, promote mineral absorption, regulate intestinal microbial flora, improve intestinal health, and prevent constipation; inhibiting the generation of toxic fermentation products, protecting liver, and preventing colon cancer; treating obesity, reducing weight; antidepression, etc.
Preferably, the Inonotus obliquus extract of the present invention is prepared using artificially cultured Inonotus obliquus mycelia. The preparation method of artificially cultured Inonotus obliquus mycelium comprises the following steps:
providing a corn mixture consisting of corn kernels, corn cobs and corn silk, wherein the corn mixture consists of the following components in parts by weight: 65-75% of corn kernels, 20-30% of corncobs and 3-7% of corn stigma;
providing rice bran;
the corn mixture and the rice bran form uniformly mixed culture medium powder, and the weight of the culture medium powder comprises the following components: 75-95% of corn mixture and 5-25% of rice bran;
adding water into the culture medium powder to form a packaged culture medium, wherein the weight of the added water is 50-150% of the weight of the culture medium powder;
inoculating the inonotus obliquus strain to the packaging culture medium for packaging culture, wherein the culture temperature is 18-30 ℃, and the culture time is 40-60 days;
and taking out all the encapsulated cultures and drying to obtain the biotransformation mycelium composition.
According to a preferred embodiment of the present invention, the corn mixture is composed of corn kernels, corn cobs and corn stigma of black corn crops, and the rice bran is millet rice bran. Compared with common light-colored corn, the black corn has advantages in the aspects of crude fiber, mineral substances (the content of iron is up to 20 percent), vitamin (such as VB1, VB2 and the like) component content and the like, which can cause that the black corn can generate strong synergistic promotion effect on the growth of inonotus obliquus mycelium under the condition of being matched with millet rice bran which has high fiber content, high porosity and difficult caking.
In addition, through years of research, the inventor believes that a proper amount of corn stigma, particularly black corn stigma, has the effect of drawing pindianjing on the efficient accumulation of active ingredients such as triterpenes in hyphae.
According to the present invention, the corn blend preferably comprises 70% corn kernels, 25% corn cobs and 5% corn silks by weight.
According to the invention, the composition of the culture medium powder is preferably 80-90% by weight of the corn mixture and 10-20% by weight of the rice bran.
According to the invention, the granularity of the culture medium powder is preferably 10-20 meshes.
In accordance with the present invention, the Inonotus obliquus strain is preferably an Inonotus obliquus (Fr) Pilat strain of the genus Fuscoporia of the family Polyporaceae.
With respect to female health. In traditional Chinese medicine, women usually take blood as the main part, and the importance of nourishing blood and enriching blood is emphasized. Qi is the commander of blood, blood is the mother of qi, qi circulation is the blood circulation, and qi stagnation is the blood stasis, so both qi and blood are emphasized. In addition, without removing excessive pathogenic heat, latent cold, food toxicity, water dampness and blood stasis, blood can not be enriched and blood can be nourished, but instead fire heat, etc. are promoted to promote dryness. Tonifying blood and moving qi, dispelling pathogenic heat, warming and latent cold, removing food toxicity, draining water and dampness, and removing blood stasis and blood, the other two herbs can complement each other.
Under the guidance of the theory of traditional Chinese medicine, the angelica, the rhizoma polygonati, the blueberries and the vitamin C in the formula of the solid beverage have the effects of tonifying qi and enriching blood, the stevia rebaudiana and the inulin have the effects of promoting gastrointestinal peristalsis and helping digestion, and the inonotus obliquus, the inulin and the aloe have the effect of removing grease, so that greasy taste caused by excessive nourishing is avoided. Through the optimized combination and synergistic effect of the components, the solid beverage provided by the invention has the effects of removing blood poison and damp poison in vivo, removing heat, tonifying deficiency, tonifying qi, moistening lung and enriching blood, thereby achieving the effects of resisting aging, maintaining beauty and keeping young.
The betulin composite solid beverage suitable for women is mainly prepared from natural plant extracts, has the effects of tonifying qi and blood, regulating menstruation, relieving pain, resisting aging and maintaining beauty for women, and is suitable for industrial production in the field of food.
Drawings
FIG. 1 is a graph comparing the scavenging capacity of the products and partial components of the examples for hydroxyl radicals.
FIG. 2 is a graph comparing the removal of DPPH by the products and partial compositions of the various examples.
Detailed Description
The technical solution of the present invention will be described in more detail and fully with reference to the following embodiments.
The main raw materials in each example were prepared by the following method:
(1) preparation of Inonotus obliquus extract: the extraction process comprises the following steps: cleaning and drying the inonotus obliquus, crushing and sieving the inonotus obliquus by a 60-mesh sieve, putting the inonotus obliquus powder into an extraction kettle, and mixing the raw materials according to a feed liquid weight ratio of 1:10 adding 70% ethanol, extracting at 60 deg.C for 4 hr, filtering, extracting the residue twice, concentrating the extractive solution, and drying to obtain Chaba extract.
(2) Preparing a polygonatum extract: removing impurities from rhizoma polygonati, cleaning, drying at 55 ℃, crushing, sieving with a 60-mesh sieve, putting rhizoma polygonati powder into an extraction kettle, and mixing the raw materials according to a feed liquid weight ratio of 1:5 adding distilled water, leaching at 60 ℃ for 3h, separating the extract, performing secondary extraction, combining the two extracts, evaporating and concentrating at 60 ℃, adding 4 times of 90% alcohol, standing for 4h, evaporating and concentrating the separated supernatant, washing the lower substance with 90% alcohol, evaporating and concentrating the washing solution at 60 ℃, mixing the two concentrates, and performing vacuum drying at 60 ℃ and 0.065MPa to obtain the sealwort extract.
(3) Preparation of the blueberry extract: cleaning blueberries, pulping, putting pulp into an extraction kettle, and mixing the pulp according to a feed liquid weight ratio of 1: adding 70% acidic ethanol into 10, soaking at 60 deg.C for 2h, centrifuging at 1200r/min for 20min, evaporating supernatant at 60 deg.C, concentrating, and vacuum drying at 60 deg.C under 0.06MPa to obtain fructus Myrtilli extract.
(4) Preparation of aloe extract: cleaning Aloe, peeling, mashing to obtain slurry, vacuum concentrating at 60 deg.C, extracting with ethyl acetate at 60 deg.C for 3 times, discarding organic phase, mixing three water phases, concentrating by evaporation, dissolving the obtained concentrate with isobutanol at 70 deg.C, cooling to 4 deg.C, crystallizing, drying the separated crystal, and pulverizing to obtain Aloe extract.
(5) Preparing an angelica extract: drying and pulverizing radix Angelicae sinensis, adding 70% ethanol at a feed liquid weight ratio of 1:1.5, soaking for 2.5h, placing in a percolation barrel, percolating at a speed of 1mL/min, collecting 20 times of percolate, recovering ethanol under reduced pressure, and drying the residual liquid at 60 deg.C to obtain radix Angelicae sinensis extract.
Inulin, vitamin C and stevioside, other ingredients, are commercially available.
Example 1
Inonotus obliquus extract: extracting with wild Chaba.
Proportioning: 16 parts of inonotus obliquus extract, 17 parts of rhizoma polygonati extract, 28 parts of blueberry extract, 4.7 parts of aloe extract, 4.7 parts of angelica sinensis extract, 24.3 parts of inulin, 4.7 parts of vitamin C and 0.6 part of stevioside.
And compounding to obtain the solid beverage EG.1.
Example 2
Inonotus obliquus extract: extracting with wild Chaba.
Proportioning: 15 parts of inonotus obliquus extract, 18 parts of rhizoma polygonati extract, 27 parts of blueberry extract, 4.7 parts of aloe extract, 4.7 parts of angelica sinensis extract, 15.3 parts of inulin, 4.7 parts of vitamin C and 0.6 part of stevioside.
And compounding to obtain the solid beverage EG.2.
Example 3
Inonotus obliquus extract: extracting with wild Chaba.
Proportioning: 16 parts of inonotus obliquus extract, 17 parts of rhizoma polygonati extract, 28 parts of blueberry extract, 4.7 parts of aloe extract, 4.7 parts of angelica sinensis extract, 24.3 parts of inulin, 4.7 parts of vitamin C and 0.6 part of stevioside.
And compounding to obtain the solid beverage EG.3.
Example 4
Inonotus obliquus extract: extracting with artificially cultured Inonotus obliquus mycelium.
Proportioning: 15 parts of inonotus obliquus extract, 18 parts of rhizoma polygonati extract, 27 parts of blueberry extract, 4.7 parts of aloe extract, 4.7 parts of angelica sinensis extract, 15.3 parts of inulin, 4.7 parts of vitamin C and 0.6 part of stevioside.
And compounding to obtain the solid beverage EG.4.
The artificially cultured Inonotus obliquus mycelium of example 4 was prepared by the following method comprising:
(1) culture substrate raw Material preparation
The black corn seeds are purchased from Chinese agricultural academy of sciences for field planting, and after the seeds are mature, the corn kernels, the corn cobs and the corn silk are respectively mixed according to the weight ratio of 70%, 25% and 5% and then crushed to form a black corn mixture for later use.
Millet bran is purchased from the market for standby.
Inonotus obliquus (Fr) Pilat strain of Inonotus obliquus (Fuscoporia obliqua) of Fuscoporia of Polyporaceae is purchased (from "northeast edible fungi research institute") and pre-cultured into mother strain for use.
(2) Artificial cultivation process
Mixing the black corn mixture and millet bran at a weight ratio of 80% to 20%, and adding purified water to obtain culture medium.
The resulting culture medium was bottled (500ml) and sterilized before inoculation with the strain stock.
Culturing at 25 deg.C for 55 days, taking out the dense mycelium block material in the bottle, and oven drying to obtain the biotransformation mycelium composition.
Oxidation resistance test
If the free radicals are generated too much or the scavenging speed is too slow, after reaching a certain amount in vivo, the free radicals can be continuously generated and cause biological effects, and macromolecular substances and various organelles can be attacked by the free radicals to cause the damage of the organism, accelerate the aging of the organism and cause various diseases.
The antioxidant capacity of the product is evaluated by measuring the clearance rate of hydroxyl free radical (. OH) and 1, 1-diphenyl-2-trinitrophenylhydrazine free radical (DPPH) in vitro.
Sample processing method
Weighing 5g of EG.1, EG.2, EG.3 and EG.4 respectively, diluting to 50mL with absolute ethyl alcohol, carrying out ultrasonic treatment for 30min, and filtering to obtain filtrate as mother liquor for later use.
(1) Ability to scavenge OH
Taking 0.1mL of mother liquor, adding 1.9mL of absolute ethanol into a 10mL test tube to prepare a working solution (1) to be detected of the sample#). Simultaneously, 2mL of the mother liquor (2) was added to each of the two other tubes#) And 2mL of absolute ethanol (0)#) And the solution is used as a solution to be detected.
Adding 1mL of FeSO with the concentration of 6mmol/L into each tube of solution to be detected respectively4Mixing the solution with 1mL of 6mmol/L salicylic acid solution, adding 0.2mL of 8mmol/L H2O2Initiation of the reaction (2)#0.2mL of distilled water was used in place of H2O2). Reacting in water bath at 37 deg.C for 30min, centrifuging at 4000rpm for 10min, collecting supernatant, and measuring absorbance at 510nm wavelength.
Hydroxyl radical clearance calculation formula: clearance (%) ═ a0-(A1-A2)]/A0×100
A02mL of absolute ethanol and 1mL of FeSO41mL salicylic acid, 0.2mL H2O2Absorbance of the reaction.
A1-2 mL sample with 1mL FeSO41mL salicylic acid, 0.2mL H2O2Absorbance of the reaction.
A2-2 mL sample with 1mL FeSO4Absorbance of the reaction was 1mL of salicylic acid and 0.2mL of distilled water.
(2) Ability to scavenge DPPH
Taking 0.1mL of mother liquor, adding 1.9mL of absolute ethanol into a 10mL test tube to prepare a working solution (1) to be detected of the sample#). Simultaneously, 2mL of the mother liquor (2) was added to each of the two other tubes#) And 2mL of absolute ethanol (0)#) And the solution is used as a solution to be detected.
And (3).0mL of 0.1mmol/L DPPH-ethanol solution was added to each tube of the test solution (2)#3mL of absolute ethyl alcohol) are used, the mixture is uniformly mixed, and the mixture is subjected to light-shielding reaction for 30min and then absorbs at the wavelength of 517 nm.
DPPH free radical clearance calculation formula: clearance (%) ═ a0-(A1-A2)]/A0×100
A0Absorbance of 2mL absolute ethanol reacted with 3mL DPPH solution.
A1Absorbance of 2mL of sample reacted with 3mL of DPPH solution.
A2Absorbance of 2mL sample reacted with 3mL absolute ethanol.
Control experiment
Processing partial components (the inonotus obliquus extract, the blueberry extract, the aloe extract and the vitamin C) according to the mixture ratio of each embodiment to ensure that the concentration of the mother liquor of the solution to be tested of each component is consistent with the mixture ratio. Thereafter, OH and DPPH clearance of each fraction was examined as described above.
Results of the experiment
As shown in FIGS. 1 and 2, the products obtained in each example have good antioxidant ability, and particularly, the solid beverage prepared by using artificially cultured Inonotus obliquus mycelium in example 4 has the best antioxidant ability.
The above description is only an embodiment of the present invention, and is not intended to limit the present invention, and all equivalent changes and modifications according to the spirit of the present invention are within the scope of the technical protection scheme of the present invention.
Claims (2)
1. The betulin composite solid beverage suitable for women comprises the following components in parts by weight:
15-18 parts of inonotus obliquus extract, 16-20 parts of rhizoma polygonati extract, 28-32 parts of blueberry extract, 3-7 parts of aloe extract, 3-7 parts of angelica extract, 22-28 parts of inulin, 4-6 parts of vitamin C and 0.5-0.8 part of stevioside.
2. A method for preparing the betulin complex solid beverage as set forth in claim 1, comprising the steps of:
(1) cleaning Chaba, drying, pulverizing, sieving, adding Chaba powder into an extraction kettle, adding 70% ethanol according to the weight ratio of 1:8-1:10 of the material liquid, extracting at 55-63 deg.C for 4-5 h, filtering, performing secondary extraction on the residue, concentrating the extract, and drying to obtain Chaba extract;
(2) removing impurities from rhizoma polygonati, cleaning, drying, crushing and sieving, putting rhizoma polygonati powder into an extraction kettle, adding distilled water according to the weight ratio of 1:3-1:5 of material liquid, soaking for 3-4h at 55-60 ℃, separating extract, performing secondary extraction, evaporating and concentrating, adding 3-5 times of 90% alcohol, standing for 3-4h, concentrating separated supernatant, washing lower substances with 90% alcohol, concentrating washing liquid again, mixing the two concentrates, and performing vacuum drying to obtain rhizoma polygonati extract;
(3) cleaning blueberry, pulping, placing the pulp into an extraction kettle, adding 70% acidic ethanol according to the weight ratio of the material liquid of 1:8-1:10, soaking at 55-60 ℃ for 1-2h, centrifuging at 1200r/min for 20min, evaporating and concentrating the supernatant, and vacuum drying at 55 ℃ to obtain a blueberry extract;
(4) cleaning aloe, peeling, mashing to obtain pulp, concentrating under reduced pressure at 40 deg.C, extracting with ethyl acetate at 55-60 deg.C for 3 times, discarding organic phase, mixing three water phases, concentrating by evaporation to obtain concentrate, dissolving with isobutanol at 70 deg.C, cooling to 4-5 deg.C, crystallizing, and drying to obtain aloe extract;
(5) drying and pulverizing radix Angelicae sinensis, adding 70% ethanol according to the weight ratio of the material liquid of 1:1-1:1.5, soaking for 2-3h, placing in a percolation barrel, percolating at 1mL/min, collecting percolate of 18-20 times, recovering ethanol under reduced pressure, and drying the residual liquid to obtain radix Angelicae sinensis extract;
(6) and (2) uniformly mixing the inonotus obliquus extract obtained in the step (1), the polygonatum sibiricum extract obtained in the step (2), the blueberry extract obtained in the step (3), the aloe extract obtained in the step (4), the angelica sinensis extract obtained in the step (5), inulin, vitamin C and stevioside according to a ratio, performing wet granulation, drying, and performing size stabilization, sterilization and packaging to obtain the inonotus obliquus compound solid beverage.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110037547.9A CN112956627A (en) | 2021-01-12 | 2021-01-12 | Compound solid drink of chaga for women |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110037547.9A CN112956627A (en) | 2021-01-12 | 2021-01-12 | Compound solid drink of chaga for women |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112956627A true CN112956627A (en) | 2021-06-15 |
Family
ID=76271505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110037547.9A Pending CN112956627A (en) | 2021-01-12 | 2021-01-12 | Compound solid drink of chaga for women |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112956627A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113796530A (en) * | 2021-08-16 | 2021-12-17 | 安徽全康药业有限公司 | Preparation process of beauty maintaining and young keeping collagen peptide germ powder |
CN115181680A (en) * | 2020-11-18 | 2022-10-14 | 山西运奕道生物科技有限公司 | Active substance extraction and blood sugar reducing application in inonotus obliquus culture |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105685754A (en) * | 2016-01-20 | 2016-06-22 | 哈尔滨瑞烨环保科技有限公司 | Inonotuso bliquus pilat compound solid beverage as well as preparation method and application thereof |
-
2021
- 2021-01-12 CN CN202110037547.9A patent/CN112956627A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105685754A (en) * | 2016-01-20 | 2016-06-22 | 哈尔滨瑞烨环保科技有限公司 | Inonotuso bliquus pilat compound solid beverage as well as preparation method and application thereof |
Non-Patent Citations (5)
Title |
---|
刘雪平: "当归有效成分分离纯化工艺的研究进展", 《内蒙古中医药》 * |
张梅梅等: "正交实验法优化桦褐孔菌多酚类物质的提取工艺研究", 《菌物学报》 * |
滕树锐等: "黄精多糖与黄酮综合提取工艺优化及硒肥对其含量的影响", 《湖北农业科学》 * |
石桂珍等: "蓝莓花青素的提取及含量分析", 《食品研究与开发》 * |
韩宗元等: "Box-Behnken法辅助微波提取芦荟苷及稳定性的研究", 《食品工业》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115181680A (en) * | 2020-11-18 | 2022-10-14 | 山西运奕道生物科技有限公司 | Active substance extraction and blood sugar reducing application in inonotus obliquus culture |
CN115181680B (en) * | 2020-11-18 | 2023-09-05 | 山西运奕道生物科技有限公司 | Active substance extraction and blood sugar reducing application in inonotus obliquus culture |
CN113796530A (en) * | 2021-08-16 | 2021-12-17 | 安徽全康药业有限公司 | Preparation process of beauty maintaining and young keeping collagen peptide germ powder |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103740566B (en) | Rosa roxbunghii medicinal liquor and preparation method thereof | |
CN112956627A (en) | Compound solid drink of chaga for women | |
CN107996757A (en) | A kind of blood pressure lowering, hypoglycemic, reducing blood lipid, the health beverages and preparation method thereof of norcholesterol | |
CN107660671A (en) | A kind of water chestnut skin drinks | |
CN108175785A (en) | Golden flower composite health beverage and preparation method thereof | |
CN110800999A (en) | Multifunctional nutritional whole powder and production method thereof | |
CN106617049A (en) | Propolis healthcare product with moringa oleifera leaf extract and method for preparing propolis healthcare product | |
KR101999675B1 (en) | Herbal composition for the prevention and treatment of coronary heart disease | |
CN106497722B (en) | Walnut flower pomegranate fruit wine and preparation method thereof | |
KR100534074B1 (en) | Cosmetic composition containing grain extract and fermented grain phellinus linteus extract, and cosmetics containing the same | |
KR101058422B1 (en) | Herbal dietary supplement and its manufacturing method | |
KR102249711B1 (en) | Composition for enhancing skin elasticity or improving skin wrinkels comprising enzyme treated extract of leguminous plants cultured root | |
CN108813500B (en) | Health-preserving honey paste with effects of tonifying middle-jiao and Qi, nourishing blood and soothing nerves and regulating human body functions | |
CN112840947A (en) | Method for cultivating cordyceps sinensis by taking hawthorn as main matrix | |
CN105087284A (en) | Compound raspberry health wine and preparation method thereof | |
KR101093006B1 (en) | Method for producing functional health food containing bezoar bovis used microbes and the functional health food produced by the same | |
CN108703924A (en) | A kind of plant Shu Min Essences and preparation method thereof | |
CN108542982B (en) | A health composition containing Agaricus blazei fine powder | |
CN111165797A (en) | Nutritional energy diet suitable for comprehensive regulation of physical functions of astronauts | |
KR102289257B1 (en) | Food composition for improving menopausal symptoms | |
Hassan et al. | Phytochemical and Ethnobotanical Effects of Aloe vera | |
KR102678842B1 (en) | Fermented beverage composition containing agar and aronia as main ingredients and method for producing the same | |
CN107692021A (en) | A kind of beautifying face and moistering lotion white fungus date cake and preparation method thereof | |
CN106361968A (en) | Traditional Chinese medicine tablets and preparation method thereof | |
CN106511613A (en) | Anthocyanidin-rich quinoa soft capsule and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210615 |